Cargando…
Effect of Cholecalciferol Supplementation on the Clinical Features and Inflammatory Markers in Hospitalized COVID-19 Patients: A Randomized, Open-Label, Single-Center Study
Recent studies showed that a low 25-hydroxyvitamin D (25(OH)D) level was associated with a higher risk of morbidity and severe course of COVID-19. Our study aimed to evaluate the effects of cholecalciferol supplementation on the clinical features and inflammatory markers in patients with COVID-19. A...
Autores principales: | Karonova, Tatiana L., Golovatyuk, Ksenia A., Kudryavtsev, Igor V., Chernikova, Alena T., Mikhaylova, Arina A., Aquino, Arthur D., Lagutina, Daria I., Zaikova, Ekaterina K., Kalinina, Olga V., Golovkin, Alexey S., Grant, William B., Shlyakhto, Evgeny V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9268385/ https://www.ncbi.nlm.nih.gov/pubmed/35807783 http://dx.doi.org/10.3390/nu14132602 |
Ejemplares similares
-
Vitamin D Status and Immune Response in Hospitalized Patients with Moderate and Severe COVID-19
por: Karonova, Tatiana L., et al.
Publicado: (2022) -
Cytokine Storm Signature in Patients with Moderate and Severe COVID-19
por: Kalinina, Olga, et al.
Publicado: (2022) -
Vitamin D Intake May Reduce SARS-CoV-2 Infection Morbidity in Health Care Workers
por: Karonova, Tatiana L., et al.
Publicado: (2022) -
Imbalanced Immune Response of T-Cell and B-Cell Subsets in Patients with Moderate and Severe COVID-19
por: Golovkin, Alexey, et al.
Publicado: (2021) -
Low 25(OH)D Level Is Associated with Severe Course and Poor Prognosis in COVID-19
por: Karonova, Tatiana L., et al.
Publicado: (2021)